Yahoo Finance

Lutris Pharma Presents New Data from Its Completed Clinical Trial of LUT014 Gel Demonstrating Efficacy in Treating Acneiform Rash Associated with Use of Anti-EGFR Cancer ...

"Due to the widespread use of EGFR inhibitors for cancer treatment and the frequent occurrence of dermal toxicities, many patients do not receive optimal cancer therapy. This is often because the ...
Forbes

Lutris Is Working On Snap And Flatpak Installers For Linux Gamers

Forbes contributors publish independent expert analyses and insights. I cover the exciting intersection of Linux and handheld gaming. Feb 08, 2019, 05:26am EST Feb 08, 2019, 05:27am EST This article ...
Yahoo Finance

Lutris Pharma Presents Additional Positive Data from Its Phase 2 Trial of LUT014 Gel Demonstrating Significant Efficacy in Treating Acneiform Rash Associated with Use of Anti ...

"EGFR inhibitors, like cetuximab and panitumumab, are critical components of cancer therapy, but their effectiveness is often compromised by skin toxicities that can lead to dose modifications or ...
PR Newswire

Lutris Pharma Receives FDA Orphan Drug Designation for LUT014 for the Treatment of EGFRI-Induced Acneiform Rash

TEL AVIV, Israel, Feb. 28, 2024 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today ...
CRN

Lutris Technologies Out of Java App Server Business

Lutris CEO and President Yancy Lind said Thursday morning that Lutris, a former open-source consulting firm that had most recently been operating as a J2EE licensee and vendor of J2EE app servers, has ...
PR Newswire

Lutris Pharma Completes Enrollment in Phase 2 Trial of LUT014 for the Treatment of EGFRI-Induced Acneiform Rash in Patients with Metastatic Colorectal Cancer

TEL AVIV, Israel, Oct. 15, 2024 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose limiting toxicity, today ...